Kohlberg Kravis Roberts & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CCI.PRA
Crown Castle International Corp.
CCI.PRA
|
+$222M |
| 2 |
OneMain Financial
OMF
|
+$11.6M |
| 3 |
AbbVie
ABBV
|
+$6.86M |
| 4 |
Labcorp
LH
|
+$5.78M |
| 5 |
Pfizer
PFE
|
+$5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.19B |
| 2 |
Zimmer Biomet
ZBH
|
+$453M |
| 3 |
DCUB
DOMINION RESOURCES INC CORP UNIT 2013 SER B (VA)
DCUB
|
+$217M |
| 4 |
NEE.PRP
NEXTERA ENERGY INC EQUITY UNIT
NEE.PRP
|
+$116M |
| 5 |
Marvell Technology
MRVL
|
+$58.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.92% |
| 2 | Consumer Staples | 24.42% |
| 3 | Technology | 9.34% |
| 4 | Industrials | 3.5% |
| 5 | Consumer Discretionary | 0.86% |
Similar funds
Kohlberg Kravis Roberts & Co's Q3 2016 Portfolio in Review
As of Q3 2016, Kohlberg Kravis Roberts & Co held 66 positions worth $8.06B, down 15% from $9.49B the previous quarter. Its ten largest holdings account for 91% of the portfolio.
Kohlberg Kravis Roberts & Co withdrew a net $1.96B in Q3 2016, closing 9 positions and reducing 6 holdings. Its most notable exit was Zimmer Biomet, an estimated $453M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 47% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Kohlberg Kravis Roberts & Co opened a new position in Crown Castle International Corp. worth $219M.
- Kohlberg Kravis Roberts & Co's largest Q3 2016 buy was Crown Castle International Corp.: 1,941,459 shares worth $219M.
- Kohlberg Kravis Roberts & Co's biggest Q3 2016 reduction was Walgreens Boots Alliance, cutting an estimated $1.19B.
- Kohlberg Kravis Roberts & Co fully exited Zimmer Biomet in Q3 2016, selling an estimated $453M.
- Kohlberg Kravis Roberts & Co's ten largest holdings make up 91% of its $8.06B portfolio in Q3 2016.
- Kohlberg Kravis Roberts & Co opened 12 new positions and closed 9 in Q3 2016.
- Kohlberg Kravis Roberts & Co's portfolio value fell 15% quarter-over-quarter to $8.06B.
Based on Kohlberg Kravis Roberts & Co's 13F filing for Q3 2016, filed 14 Nov 2016.